| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Oct―10 |
Hyperbaric Oxygen Therapy as an Immunomodulatory Intervention in COVID-19-induced ARDS: Exploring Clinical Outcomes and Transcriptomic Signatures in a Randomised Controlled Trial |
Anders Kjellberg, Allan Zhao, Anna Lussier, Adrian Hassler, Sarah Al-Ezerjawi, Emil Boström, et al. (+4) Sergiu-Bogdan Catrina, Peter Bergman, Kenny Alexandra Rodriguez-Wallberg, Peter Lindholm |
| 2 |
[GO] |
2023―Mar―27 |
Inhaled nebulised unfractionated heparin (UFH) for the treatment of hospitalised patients with COVID-19: A randomised controlled pilot study |
Gilberto DeNucci, Tom Wilkinson, Carlos Sverdloff, Tainah Babadopulos, Ashley Woodcock, Jan Shute, et al. (+6) Pedro Renato Guazelli, Federico Gerbasse, Paulo A.S. Mourão, Dave Singh, Frank M.P. van Haren, Clive Page |
| 3 |
[GO] |
2023―Jan―10 |
Establishment of multicenter COVID-19 therapeutics preclinical test system in Republic of Korea |
Hyuna Noh, Suhyeon Yoon, Sung-Hee Kim, Jiseon Kim, Jung Seon Seo, Jeong Jin Kim, et al. (+45) In Ho Park, Jooyeon Oh, Joon-Yong Bae, Gee Eun Lee, Sun-Je Woo, Sun-Min Seo, Na-Won Kim, Youn Woo Lee, Hui Jeong Jang, Seung-Min Hong, Se-Hee An, Kwang-Soo Lyoo, Minjoo Yeom, Hanbyeul Lee, Bud Jung, Sun-Woo Yoon, Jung-Ah Kang, Sang-Hyuk Seok, Yu Jin Lee, Seo Yeon Kim, Young Been Kim, Ji-Yeon Hwang, Dain On, Soo-Yeon Lim, Sol Pin Kim, Ji Yun Jang, Ho Lee, Kyoungmi Kim, Hyo-Jung Lee, Hong Bin Kim, Sun Bean Kim, Jun Won Park, Dae Gwin Jeong, Daesub Song, Kang-Seuk Choi, Ho-Young Lee, Yang-Kyu Choi, Jung-ah Choi, Manki Song, Man-Seong Park, Jun-Young Seo, Jeon-Soo Shin, Jun-Won Yun, Ki Taek Nam, Je Kyung Seong |
| 4 |
[GO] |
2023―Jan―02 |
Patients with moderate to severe COVID-19 outcomes on remdesivir according to baseline 4C mortality score |
Jacob Sellers, Jongwha Chang, Jessica Jones, Trager D. Hintze |
| 5 |
[GO] |
2022―Oct―18 |
Considerations into pharmacogenomics of COVID-19 pharmacotherapy: Hope, hype and reality |
Anmar AL-Taie, Ayşe Şeyma Büyük, Semra Sardas |
| 6 |
[GO] |
2021―Dec―18 |
Effects of corticosteroids on Covid-19 patients: A systematic review and meta-analysis on clinical outcomes |
Faegheh Ebrahimi Chaharom, Leili Pourafkari, Ali Asghar Ebrahimi Chaharom, Nader D. Nader |
| 7 |
[GO] |
2021―Dec―17 |
Preliminary study regarding the predicted body weight-based dexamethasone therapy in patients with COVID-19 pneumonia |
Yuri Isaka, Yasutaka Hirasawa, Jiro Terada, Yu Shionoya, Yuichiro Takeshita, Toru Kinouchi, et al. (+6) Ken Koshikawa, Hiroshi Tajima, Taku Kinoshita, Yuji Tada, Koichiro Tatsumi, Kenji Tsushima |
| 8 |
[GO] |
2021―Oct―09 |
Management of severe asthma during the first lockdown phase of SARS-CoV-2 pandemic: tips for facing the second wave |
Benfante Alida, Principe Stefania, Cicero Maria Noemi, Incandela Maria, Seminara Gabriele, Durante Carmen, Scichilone Nicola |
| 9 |
[GO] |
2021―Aug―10 |
Evaluation of the Prophylactic Effect of Hydroxychloroquine on People in Close-Contact with Patients with Covid-19 |
Minoosh Shabani, Mehdi Totonchi, Omidvar Rezaeimirghaed, Latif Gachkar, Mohammadreza Hajiesmaeili, Ali Khoshkar, et al. (+10) Mahdi Amirdosara, Ali Saffaei, Shervin Shokouhi, Masoud Mardani, Ilad Alavi Darazam, Alireza Karami, Milad Sharifi, Mana Zaman, Elham Abedheydari, Zahra Sahraei |
| 10 |
[GO] |
2021―Jul―13 |
Fibrinolytic or anti-plasmin (nafamostat) therapy for COVID-19: a timing challenge for clinicians |
Hong-Long Ji, Brant M. Wagener, Timothy J. Ness, Runzhen Zhao |
| 11 |
[GO] |
2021―Jun―24 |
The impact of SARS-COV2 pandemic on the management oF IPF patients: Our narrative experience |
Alida Benfante, Riccardo Messina, Ilaria Piccionello, Rosangela Di Liberti, Stefania Principe, Nicola Scichilone |
| 12 |
[GO] |
2021―Jun―12 |
Inhaled bronchodilators use and clinical course of adult inpatients with Covid-19 pneumonia in Spain: A retrospective cohort study |
Elena Villamañán, Carmen Sobrino, Carlos Carpio, Marta Moreno, Ana Arancón, Catalina Lara, et al. (+6) Ester Pérez, Carlos Jiménez, Ester Zamarrón, Inmaculada Jiménez-Nácher, Alicia Herrero, Rodolfo Álvarez-Sala |
| 13 |
[GO] |
2021―May―21 |
Tofacitinib reduces mortality in coronavirus disease 2019 Tofacitinib in COVID-19 |
Roman Maslennikov, Vladimir Ivashkin, Ekaterina Vasilieva, Maxim Chipurik, Polina Semikova, Victoria Semenets, et al. (+6) Tatyana Russkova, Anna Levshina, Diana Grigoriadis, Shamil Magomedov, Irina Efremova, Natiya Dzhakhaya |
| 14 |
[GO] |
2021―Apr―30 |
Endothelin Antagonism and Sodium Glucose Co-transporter 2 Inhibition A Potential Combination Therapeutic Strategy for COVID-19 |
Marie Fisk, Magnus Althage, Sven Moosmang, Peter J. Greasley, Andrew P. Cope, David RW. Jayne, et al. (+5) James Galloway, Frances Hall, Ian B. Wilkinson, Philip Ambery, Joseph Cheriyan |
| 15 |
[GO] |
2021―Mar―14 |
Sequential doxycycline and colchicine combination therapy in Covid-19: The salutary effects |
Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Naeem Qusty, Natália Cruz-Martins, Gaber El-Saber Batiha |
| 16 |
[GO] |
2021―Jan―18 |
Antihistamines and azithromycin as a treatment for COVID-19 on primary health care - A retrospective observational study in elderly patients |
Juan Ignacio Morán Blanco, Judith A. Alvarenga Bonilla, Sakae Homma, Kazuo Suzuki, Philip Fremont-Smith, Karina Villar Gómez de las Heras |
| 17 |
[GO] |
2020―Nov―28 |
Scope of adjuvant therapy using roflumilast, a PDE-4 inhibitor against COVID-19 |
Sugin Lal Jabaris S, Ranju V |
| 18 |
[GO] |
2020―Aug―29 |
Dual-Histamine Receptor Blockade with Cetirizine - Famotidine Reduces Pulmonary Symptoms in COVID-19 Patients |
Reed B. Hogan, Reed B. Hogan, Tim Cannon, Maria Rappai, John Studdard, Doug Paul, Thomas P. Dooley |
|
